Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
Clinical trial NCT04004065 · TERMINATED
Trial details
- NCT number
- NCT04004065
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2023-10-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.